Published by Alexander Bueso on 11th October 2021
(Sharecast News) - Merck and Ridgeback Biotherepautics have filed for Emergency Use Approval of their oral antiviral for mild-to-moderate cases of Covid-19 with America's lead regulator, the U.S. Food and Drug Administration.
URL: http://www.digitallook.com/dl/news/story/32183250/...